Amgen to Present at the Goldman Sachs Global Healthcare Conference
THOUSAND OAKS, Calif., June 15 Amgen (Nasdaq: AMGN) will present at the Goldman Sachs Global Healthcare Conference on Thursday, June 17, 2010 at the Century Plaza Hyatt Regency, Los Angeles, beginning at 9:20 a.m. Pacific Time. Amgen Chairman and CEO Kevin Sharer will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's website, www.amgen.com, under Investors.
Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks David Polk, 805-447-4613 (media) Arvind Sood, 805-447-1060 (investors)
You May Also Like